Pfizer reports 1st quarterly loss since 2019 on weak COVID product demand
Pfizer on Tuesday reported weak demand for its COVID vaccine and treatment, which pushed the drugmaker to its first quarterly loss since 2019.
Pfizer on Tuesday reported weak demand for its COVID vaccine and treatment, which pushed the drugmaker to its first quarterly loss since 2019.
